Life Sciences insights
30 results found
LLM Clinical Trial Matcher Demo
This demo walks though WWT's lab on LLM Clinical Trial Matcher. The recruitment of patients for clinical trials presents significant challenges for pharmaceutical companies, often delaying drug development, increasing cost, and leaded to study failure. This lab explores how AI applied to anonymized health records enables efficient trial matching—at single, bulk, and multi-trial levels—reducing time, improving accuracy, and enhancing access for researchers, providers, and patients.
LLM Powered Clinical Trial Matcher
The recruitment of patients for clinical trials presents significant challenges for pharmaceutical companies, often delaying drug development, increasing cost, and lead to study failure. This lab explores how AI applied to anonymized health records enables efficient trial matching—at single, bulk, and multi-trial levels—reducing time, improving accuracy, and enhancing access for researchers, providers, and patients.
Pediatric Vaccine Assistant
Primary care and pediatric providers can spend significant time manually cross-referencing multiple sources to construct accelerated catch-up protocols for unvaccinated or under-vaccinated patients. The Pediatric Vaccine Assistant streamlines this workflow, reducing administrative burden and supporting evidence-based care.
Life Sciences and AI with Dr. Sanaz Cordes
As in many verticals, AI has become more challenging in Life Sciences. Listen as WWT's Chief Healthcare Advisor, Dr. Sanaz Cordes, reviews some of these challenges. Dr. Cordes reviews the Life Sciences framework and the increased demand for AI.
LLM-Powered Clinical Trial Matcher
This article showcases the power of LLMs and RAG to reduce manual effort and improve consistency in one of clinical research's most persistent bottlenecks: patient matching.
Top-tier Pharma Achieves OT Cybersecurity Across Plants Globally
WWT deployed a global OT cybersecurity solution for a top-tier pharmaceutical company. Our efforts achieved visibility of IT and operational technology (OT) assets, plus vulnerability detection across plants globally.
Enhancing the Security Posture of a Global Life Sciences Organization
A life sciences organization collaborated with World Wide Technology to find a solution that not only provided backup capabilities but also true cyber resilience.
Securing AI for Healthcare and Life Sciences
In the rapidly evolving landscape of Life Sciences & Healthcare cybersecurity, the role of a Chief Information Security Officer (CISO) has never been more challenging. According to Gartner, 80% of CIOs plan to increase their cybersecurity investments in 2024. This increase is driven by the expanding attack surface, increase in scope and public visibility to ransomware incidents, and the rapid proliferation of generative AI (GenAI) use cases, which introduce new and unknown risks. As AI adoption grows, so too do the security challenges it presents. But how can security teams support safe innovation while mitigating new risks?
Global Pharmaceutical Company Accelerates Comparison of SASE Solutions
WWT helped the company execute a proof of concept as it prepares for a divestiture.
Cyber Resiliency for Life Sciences & Healthcare
Cyber adversaries are evolving their techniques at an alarming rate. Attackers are increasingly looking for disruption, nation-state retaliation, brand reputation, and destruction aside from just ransoming of data. We are seeing production infrastructure such as hypervisors, storage, network, PKI and MFA systems compromised and destroyed, causing you to have to rebuild from bare metal. In this session we will discuss the current threat landscape, current techniques being observed, an overview of WWT's Cyber Resilience methodology and dive into some technical details around a Cyber Resilience Vault.
Pharma Spin-off Taps WWT for IT Infrastructure Build with "Impossible" Deadline
WWT partnered with a global pharmaceutical company to design and build a greenfield IT infrastructure, enabling the $3 billion business to spin-off from its parent company within an aggressive Transition Services Agreement (TSA) deadline, saving the new entity $28 million.
Optimizing Cloud Strategies for High-Performance Computing in Life Sciences
The life sciences industry is undergoing a significant shift, with 33 percent of investment dollars expected to go toward AI by 2025. This surge in AI adoption is driving an increased need for high-performance computing (HPC) to power genomics, proteomics and other data-intensive research. In this episode of WWT Experts, Chief Healthcare and Global Life Sciences Advisor Dr. Sanaz Cordes and Technical Solutions Architect Derrick Monahan discuss how organizations can leverage cloud for HPC based on key business and technical considerations.